These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28193065)

  • 21. Collisional activation of peptide ions in FT-ICR mass spectrometry.
    Laskin J; Futrell JH
    Mass Spectrom Rev; 2003; 22(3):158-81. PubMed ID: 12838543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystallization of bacteriorhodopsin solubilized by a tripod amphiphile.
    Theisen MJ; Potocky TB; McQuade DT; Gellman SH; Chiu ML
    Biochim Biophys Acta; 2005 Aug; 1751(2):213-6. PubMed ID: 15963773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of cytochrome c unfolding by nano-electrospray ionization time-of-fight and Fourier transform ion cyclotron resonance mass spectrometry.
    Youhnovski N; Matecko I; Samalikova M; Grandori R
    Eur J Mass Spectrom (Chichester); 2005; 11(5):519-24. PubMed ID: 16322658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assigning product ions from complex MS/MS spectra: the importance of mass uncertainty and resolving power.
    Sleno L; Volmer DA; Marshall AG
    J Am Soc Mass Spectrom; 2005 Feb; 16(2):183-98. PubMed ID: 15694769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystallization in lipidic cubic phases: a case study with bacteriorhodopsin.
    Gordeliy VI; Schlesinger R; Efremov R; Büldt G; Heberle J
    Methods Mol Biol; 2003; 228():305-16. PubMed ID: 12824562
    [No Abstract]   [Full Text] [Related]  

  • 26. Fourier-transform ion cyclotron resonance mass spectrometry for characterizing proteoforms.
    Tucholski T; Ge Y
    Mass Spectrom Rev; 2022 Mar; 41(2):158-177. PubMed ID: 32894796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of Hemoglobinopathy and β-Thalassemia by 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry and Tandem Mass Spectrometry of Hemoglobin from Blood.
    He L; Rockwood AL; Agarwal AM; Anderson LC; Weisbrod CR; Hendrickson CL; Marshall AG
    Clin Chem; 2019 Aug; 65(8):986-994. PubMed ID: 31040099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of large ions in FT-ICR mass spectrometry.
    Laskin J; Futrell JH
    Mass Spectrom Rev; 2005; 24(2):135-67. PubMed ID: 15389858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unfolding pathways of individual bacteriorhodopsins.
    Oesterhelt F; Oesterhelt D; Pfeiffer M; Engel A; Gaub HE; Müller DJ
    Science; 2000 Apr; 288(5463):143-6. PubMed ID: 10753119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative XANES analysis of the calcium high-affinity binding site of the purple membrane.
    Sepulcre F; Proietti MG; Benfatto M; Della Longa S; García J; Padrós E
    Biophys J; 2004 Jul; 87(1):513-20. PubMed ID: 15240484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical and electric signals from dried oriented purple membrane of bacteriorhodopsins.
    Tóth-Boconádi R; Dér A; Keszthelyi L
    Bioelectrochemistry; 2011 Apr; 81(1):17-21. PubMed ID: 21236739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel glycolipid and phospholipid in the purple membrane.
    Corcelli A; Colella M; Mascolo G; Fanizzi FP; Kates M
    Biochemistry; 2000 Mar; 39(12):3318-26. PubMed ID: 10727224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-protein interactions in the purple membrane: structural specificity within the hydrophobic domain.
    Pomerleau V; Harvey-Girard E; Boucher F
    Biochim Biophys Acta; 1995 Mar; 1234(2):221-4. PubMed ID: 7696297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Culture temperature affects the molecular motion of bacteriorhodopsin within the purple membrane.
    Kikukawa T; Araiso T; Mukasa K; Shimozawa T; Kamo N
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):473-6. PubMed ID: 8882448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallinity of purple membranes comprising the chloride-pumping bacteriorhodopsin variant D85T and its modulation by pH and salinity.
    Rhinow D; Chizhik I; Baumann RP; Noll F; Hampp N
    J Phys Chem B; 2010 Nov; 114(46):15424-8. PubMed ID: 21033713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The coupling of direct analysis in real time ionization to Fourier transform ion cyclotron resonance mass spectrometry for ultrahigh-resolution mass analysis.
    Rummel JL; McKenna AM; Marshall AG; Eyler JR; Powell DH
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):784-90. PubMed ID: 20187081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and confirmation criteria for hormone residue analysis using liquid chromatography accurate mass time-of-flight, Fourier transform ion cyclotron resonance and orbitrap mass spectrometry techniques.
    Nielen MW; van Engelen MC; Zuiderent R; Ramaker R
    Anal Chim Acta; 2007 Mar; 586(1-2):122-9. PubMed ID: 17386703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Top-Down Proteomics Platform Coupling Serial Size Exclusion Chromatography and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Tucholski T; Knott SJ; Chen B; Pistono P; Lin Z; Ge Y
    Anal Chem; 2019 Mar; 91(6):3835-3844. PubMed ID: 30758949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface structures of native bacteriorhodopsin depend on the molecular packing arrangement in the membrane.
    Müller DJ; Sass HJ; Müller SA; Büldt G; Engel A
    J Mol Biol; 1999 Feb; 285(5):1903-9. PubMed ID: 9925773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.